SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-016015
Filing Date
2022-01-24
Accepted
2022-01-24 16:05:37
Documents
12
Period of Report
2022-01-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d299391d8k.htm   iXBRL 8-K 25675
  Complete submission text file 0001193125-22-016015.txt   151656

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rphm-20220118.xsd EX-101.SCH 2869
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rphm-20220118_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rphm-20220118_pre.xml EX-101.PRE 11716
6 EXTRACTED XBRL INSTANCE DOCUMENT d299391d8k_htm.xml XML 3474
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40315 | Film No.: 22549362
SIC: 2834 Pharmaceutical Preparations